Key result
The DECAF score independently predicted 30-day mortality (OR 1.505) in older patients presenting to the emergency department with dyspnea due to cardiopulmonary diseases.
Why the study?
The study aimed to investigate the prognostic value of DECAF, BAP-65, and CURB-65 scores for predicting hospitalization and 30-day mortality in elderly patients with COPD, asthma, CAP, or CHF.
Does the DECAF score effectively predict hospitalization, ICU admission, and 30-day mortality in elderly patients presenting with dyspnea compared to BAP-65 and CURB-65 scores?
Population
369 patients aged 60 years hospitalized for exacerbations of COPD, asthma, CAP, or CHF
Comparison
DECAF vs BAP-65 vs CURB-65 scores
Design
Retrospective study
Follow-up
30 days
Authors
Loading...
DECAF may aid risk stratification in elderly dyspnea; leaves open whether it outperforms BAP-65 or CURB-65 prospectively.
Observational (n=369)
No
Does the DECAF score effectively predict hospitalization, ICU admission, and 30-day mortality in elderly patients presenting with dyspnea compared to BAP-65 and CURB-65 scores?
Odds Ratio: 1.505 (95% CI 1.05–2.156)
p-value: p=0.026
The DECAF score is an effective and superior tool compared to the CURB-65 score for predicting 30-day mortality, hospitalization, and ICU admission in elderly patients presenting to the emergency department with dyspnea.
Bayramoğlu et al. (2023) conducted an observational in Dyspnea (COPD, asthma, community-acquired pneumonia, or congestive heart failure) (n=369). DECAF score vs. BAP-65 and CURB-65 scores was evaluated on 30-day mortality (OR 1.505, 95% CI 1.05-2.156, p=0.026). The DECAF score independently predicted 30-day mortality (OR 1.505) in older patients presenting to the emergency department with dyspnea due to cardiopulmonary diseases.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: